Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

What Doctors Don't Tell You

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!
September 2019 (Vol. 4 Issue 7)

Immunotherapy a cancer game changer? Curb the enthusiasm
About the author: 
Bryan Hubbard

Immunotherapy a cancer game changer? Curb the enthusiasm image

Immunotherapy, the new cancer treatment that harnesses the body’s own immune system, has once again been described as a ‘game-changer’ after a new study has found it helped people with head and neck cancers live longer. But while anything is better than chemotherapy, it’s not quite the magic bullet that drug companies are claiming.

For one, those given the immunotherapy drug nivolumab did live longer than others who had chemotherapy—but only by a few months. In the new study involving 350 patients with head and neck cancer, 36 per cent of the immunotherapy patients were still alive a year later, which also means that 64 per cent weren’t helped by the drug, compared to 17 per cent of patients given chemotherapy.

The results were slightly better among patients who were also HPV-positive; they lived an average of nine months, which was slightly more than double the survival time with chemotherapy, say researchers from the Royal Marsden Hospital in London.

While any extension of life is welcome, does it make immunotherapy a game changer? An analysis of the new therapy in September’s What Doctors Don’t Tell You magazine (https://www.wddty.com/magazine/2016/september/immunotherapy-hype-or-hope.html) discovered that drug company profits were as much to do with the zeal surrounding immunotherapy as any benefit to the patient. Bad news was also being swept under the carpet by the drug company and regulators; one immunotherapy drug had been responsible for five deaths—which was 25 per cent of those given the treatment—and two further deaths in 2014.


References

(Source: proceedings of the European Cancer Congress, October 9, 2016)

You may also be interested in...

Support WDDTY

Help support us to hold the drugs companies, governments and the medical establishment accountable for what they do.

Advertisements

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions..

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

© 2010 - 2019 WDDTY Publishing Ltd.
All Rights Reserved